Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Confidential contracting

Bristol-Myers Squibb (BMS) building

BMS presses go on Nektar combo pivotal trials, despite data debate

The data isn’t mature enough to give an accurate ORR reading, says companies

- PMLiVE

Changes to look out for in Medical Devices Regulations

Will digital lead to a greater compliance burden?

- PMLiVE

Brave real world? How healthcare communication needs to adapt

The evaluation of drugs and medical devices has moved into a new era. Randomised clinical trials (RCTs) remain the gold standard for evaluating efficacy and safety, however, their limitations are...

- PMLiVE

Protecting patient privacy

The most effective approaches  to compliance

- PMLiVE

Digging deeper to connect with the powerful force of patient understanding

EphMRA's president Karsten Trautmann advocates a holistic approach to market research

Getting multichannel marketing right

How the atomisation of communication is challenging and benefiting pharma

- PMLiVE

Tracking comms trends: beyond the event

There’s no substitute for face-to-face meetings. But meetings require a significant investment, with often substantial venue and travel costs, as well as the opportunity costs of the audience and organiser’s...

- PMLiVE

The Difference Collective boosts its creative and media offerings

Stuart Mayell and Jo Willey join the group

- PMLiVE

Kevin Sin joins GSK

He becomes senior VP, head of worldwide business development

- PMLiVE

NICE backs Tesaro’s Zejula via the CDF

Recommends the drug for second-line use in ovarian cancer patients

AstraZeneca AZ

PMCPA takes AZ to task over asthma drug press release

Concluded that the data in the release had not been “placed in context”

- PMLiVE

Pfizer’s Xeljanz picks up a third indication in the US

The JAK inhibitor can now treat patients with ulcerative colitis

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links